Education
About Us
Working with TipRanks
Follow Us
AFC-HD AMS Life Science Co., Ltd. (JP:2927)
:2927
RESEARCH TOOLSreports
Total Valuation
AFC-HD AMS Life Science Co., Ltd. has a market cap or net worth of ¥12.43B. The enterprise value is ¥24.94B.
Market Cap¥12.43B
Enterprise Value¥24.94B
Share Statistics
AFC-HD AMS Life Science Co., Ltd. has 14,387,699 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding14,387,699
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
AFC-HD AMS Life Science Co., Ltd.’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 3.20%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)3.20%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee30.37M
Profits Per Employee1.92M
Employee Count994
Asset Turnover0.64
Inventory Turnover3.29
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio7.2
PS Ratio0.00
PB Ratio0.85
Price to Fair Value0.00
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio0.90
Income Statement
In the last 12 months, AFC-HD AMS Life Science Co., Ltd. had revenue of 30.19B and earned 1.25B in profits. Earnings per share was 89.01.
Revenue30.19B
Gross Profit10.49B
Operating Income1.92B
Pretax Income1.91B
Net Income1.25B
EBITDA3.10B
Earnings Per Share (EPS)89.01
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
AFC-HD AMS Life Science Co., Ltd. pays an annual dividend of ¥18, resulting in a dividend yield of 3.49%
Dividend Per Share¥18
Dividend Yield3.49%
Payout Ratio25.15%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.50
52-Week Price Change3.54%
50-Day Moving Average867.32
200-Day Moving Average842.86
Relative Strength Index (RSI)63.78
Average Volume (3m)19.54K
Important Dates
AFC-HD AMS Life Science Co., Ltd. upcoming earnings date is Oct 10, 2025, TBA (Confirmed).
Last Earnings DateJul 15, 2025
Next Earnings DateOct 10, 2025
Ex-Dividend DateAug 28, 2025
Financial Position
AFC-HD AMS Life Science Co., Ltd. as a current ratio of 1.25, with Debt / Equity ratio of 162.16%
Current Ratio1.25
Quick Ratio0.91
Debt to Market Cap0.00
Net Debt to EBITDA3.46
Interest Coverage Ratio18.92
Taxes
In the past 12 months, AFC-HD AMS Life Science Co., Ltd. has paid 665.40M in taxes.
Income Tax665.40M
Effective Tax Rate0.35
Enterprise Valuation
AFC-HD AMS Life Science Co., Ltd. EV to EBITDA ratio is 3.46, with an EV/FCF ratio of -5.74.
EV to Sales0.36
EV to EBITDA3.46
EV to Free Cash Flow-5.74
EV to Operating Cash Flow6.96
Balance Sheet
AFC-HD AMS Life Science Co., Ltd. has ¥11.43B in cash and marketable securities with ¥24.17B in debt, giving a net cash position of ¥12.74B billion.
Cash & Marketable Securities¥11.43B
Total Debt¥24.17B
Net Cash¥12.74B
Net Cash Per Share¥885.48
Tangible Book Value Per Share¥0.00
Margins
Gross margin is 33.53%, with operating margin of 6.35%, and net profit margin of 4.15%.
Gross Margin33.53%
Operating Margin6.35%
Pretax Margin6.33%
Net Profit Margin4.15%
EBITDA Margin10.26%
EBIT Margin6.67%
Analyst Forecast
The average price target for AFC-HD AMS Life Science Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast11.47%
EPS Growth Forecast29.21%